Related Experiment Video
Updated: May 23, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
A Gastrodia elata polysaccharide for restoring intestinal immunocompromise
Zhuowen Chen1, Ling Li1, Lanping Guo2
1School of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, China; Key Laboratory of Sustainable Utilization of Panax Notoginseng Resources of Yunnan Province, Kunming 650500, China.
Abstract:
We here extracted a polysaccharide fragment from Gastrodia elata, characterized by a main chain connected via (1 → 4)-α-D-Glcp bonds, with terminal α-D-Glcp-(1→) linked to the main chain through O-6 of (1 → 4,6)-α-D-Glcp and O-3 of (1 → 3,4)-α-D-Glcp (SRGP). Both in vitro and in vivo experiments demonstrated that SRGP activates the TLR4/NF-κB signaling pathway, exerting immunomodulatory effects and alleviating cyclophosphamide (CTX)-induced intestinal mucosal damage in mice. High-throughput 16S rRNA sequencing further revealed that SRGP restores gut microbiota composition and enhances the abundance of specific bacterial populations. Additionally, SRGP improves CTX-induced intestinal mucosal damage by upregulating tight junction proteins, mitigating gut microbiota dysbiosis, and regulating both the overall microbial community and the levels of specific bacteria.
Related Concept Videos
What is Monogastric Digestion?
Renewal of Intestinal Stem Cells
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

